There has been an increasing role of magnetic resonance imaging (MRI) in the
management of prostate cancer. MRI already plays an essential role in the detection and …

Nearly 15% of individuals with localized prostate cancer are identified as high risk for
recurrence and progression of the disease, which is why the correct staging is vital for the …

CT and MRI are both commonly used in prostate cancer (PCa) management, which includes
a large spectrum from screening positive pre-diagnosis phase to metastatic disease. CT and …

Background Despite modern imaging modalities, lymph-node staging before radical
prostatectomy (RP) remains challenging in patients with prostate cancer (PCa). The visibility …

Accurate staging of prostate cancer (PCa) at initial diagnosis and at biochemical recurrence
is important to determine prognosis and the optimal treatment strategy. To date, treatment of …

Background: Prostate-specific membrane antigen (PSMA) positron emission
tomography/computed tomography (PET/CT) is coming up as a superior imaging tool for …

This study used linked, routinely-collected datasets to explore incidence, clinical
characteristics and outcomes of prostate cancer (PC) patients who experience a rise in …

New imaging techniques are more sensitive in prostate cancer and reveal sites of disease
that may never have been seen with conventional imaging, resulting in stage migration and …

Prostate cancer remains a significant global health concern, necessitating continuous
research and innovation in treatment modalities. This review explores the currently …

The extent of prostate cancer (PC) with imaging is crucial for therapeutic decision-making,
particularly in patients suffering from high-risk localized PC or at risk of extended disease …